BOLT
Bolt Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.90
+0.13%Aug 11, 2026, 20:05 UTC
Bolt Biotherapeutics reported its financial results for the second quarter ended June 30, 2026, and provided a business update.
Source:
NASDAQ · Healthcare · Biotechnology · US
Aug 11, 2026, 20:05 UTC